EMEA (Europe, Middle East and Africa) Injectable Anticoagulants Market 2017 Forecast to 2022

December 2017 | 122 pages | ID: E6337479BCFEN
GlobalInfoResearch

Abstracts

'The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).

In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.'

Scope of the Report:

This report focuses on the Injectable Anticoagulants in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Sanofi
• Genentech (Roche)
• Boehringer Ingelheim
• Pfizer
• The Medicines Company
• Aspen
• Otsuka

Market Segment by Regions, regional analysis covers

• Europe (Germany, France, UK, Russia, Italy and Turkey)
• Middle East (Saudi Arabia, Israel, UAE and Iran)
• Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

• Low-molecular-weight Heparin (LMWH)
• Direct Thrombin Inhibitor (DTI)
• Other

Market Segment by Applications, can be divided into

• VTE
• ACS/MI
• AF
• Other

There are 13 Chapters to deeply display the EMEA Injectable Anticoagulants market.

Chapter 1, to describe Injectable Anticoagulants Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Injectable Anticoagulants, with sales, revenue, and price of Injectable Anticoagulants, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Injectable Anticoagulants, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Injectable Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Injectable Anticoagulants research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Injectable Anticoagulants Introduction
1.2 Market Analysis by Type
  1.2.1 Low-molecular-weight Heparin (LMWH)
  1.2.2 Direct Thrombin Inhibitor (DTI)
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 VTE
  1.3.2 ACS/MI
  1.3.3 AF
  1.3.4 Other
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Sanofi
  2.1.1 Business Overview
  2.1.2 Injectable Anticoagulants Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Genentech (Roche)
  2.2.1 Business Overview
  2.2.2 Injectable Anticoagulants Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
  2.3.1 Business Overview
  2.3.2 Injectable Anticoagulants Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Injectable Anticoagulants Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 The Medicines Company
  2.5.1 Business Overview
  2.5.2 Injectable Anticoagulants Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Aspen
  2.6.1 Business Overview
  2.6.2 Injectable Anticoagulants Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Otsuka
  2.7.1 Business Overview
  2.7.2 Injectable Anticoagulants Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA INJECTABLE ANTICOAGULANTS MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Injectable Anticoagulants Sales and Market Share by Manufacturer
3.2 EMEA Injectable Anticoagulants Revenue and Market Share by Manufacturer
3.3 EMEA Injectable Anticoagulants Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Injectable Anticoagulants Manufacturer Market Share
  3.4.2 Top 5 Injectable Anticoagulants Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA INJECTABLE ANTICOAGULANTS MARKET ANALYSIS BY REGIONS

4.1 EMEA Injectable Anticoagulants Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Injectable Anticoagulants Sales by Regions (2012-2017)
  4.1.2 EMEA Injectable Anticoagulants Revenue by Regions (2012-2017)
4.2 Europe Injectable Anticoagulants Sales and Growth (2012-2017)
4.3 Middle East Injectable Anticoagulants Sales and Growth (2012-2017)
4.4 Africa Injectable Anticoagulants Sales and Growth (2012-2017)

5 EUROPE INJECTABLE ANTICOAGULANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Injectable Anticoagulants Sales, Revenue and Market Share by Countries
  5.1.1 Europe Injectable Anticoagulants Sales by Countries (2012-2017)
  5.1.2 Europe Injectable Anticoagulants Revenue by Countries (2012-2017)
  5.1.3 Germany Injectable Anticoagulants Sales and Growth (2012-2017)
  5.1.4 France Injectable Anticoagulants Sales and Growth (2012-2017)
  5.1.5 UK Injectable Anticoagulants Sales and Growth (2012-2017)
  5.1.6 Russia Injectable Anticoagulants Sales and Growth (2012-2017)
  5.1.7 Italy Injectable Anticoagulants Sales and Growth (2012-2017)
  5.1.8 Turkey Injectable Anticoagulants Sales and Growth (2012-2017)
5.2 Europe Injectable Anticoagulants Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Injectable Anticoagulants Sales by Manufacturers (2016-2017)
  5.2.2 Europe Injectable Anticoagulants Revenue by Manufacturers (2016-2017)
5.3 Europe Injectable Anticoagulants Sales by Type (2012-2017)
5.4 Europe Injectable Anticoagulants Sales by Application (2012-2017)

6 MIDDLE EAST INJECTABLE ANTICOAGULANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Injectable Anticoagulants Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Injectable Anticoagulants Sales by Countries (2012-2017)
  6.1.2 Middle East Injectable Anticoagulants Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Injectable Anticoagulants Sales and Growth (2012-2017)
  6.1.4 Israel Injectable Anticoagulants Sales and Growth (2012-2017)
  6.1.5 UAE Injectable Anticoagulants Sales and Growth (2012-2017)
  6.1.6 Iran Injectable Anticoagulants Sales and Growth (2012-2017)
6.2 Middle East Injectable Anticoagulants Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Injectable Anticoagulants Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Injectable Anticoagulants Revenue by Manufacturers (2016-2017)
6.3 Middle East Injectable Anticoagulants Sales by Type (2012-2017)
6.4 Middle East Injectable Anticoagulants Sales by Application (2012-2017)

7 AFRICA INJECTABLE ANTICOAGULANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Injectable Anticoagulants Sales, Revenue and Market Share by Countries
  7.1.1 Africa Injectable Anticoagulants Sales by Countries (2012-2017)
  7.1.2 Africa Injectable Anticoagulants Revenue by Countries (2012-2017)
  7.1.3 South Africa Injectable Anticoagulants Sales and Growth (2012-2017)
  7.1.4 Nigeria Injectable Anticoagulants Sales and Growth (2012-2017)
  7.1.5 Egypt Injectable Anticoagulants Sales and Growth (2012-2017)
  7.1.6 Algeria Injectable Anticoagulants Sales and Growth (2012-2017)
7.2 Middle East Injectable Anticoagulants Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Injectable Anticoagulants Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Injectable Anticoagulants Revenue by Manufacturers (2016-2017)
7.3 Middle East Injectable Anticoagulants Sales by Type (2012-2017)
7.4 Middle East Injectable Anticoagulants Sales by Application (2012-2017)

8 EMEA INJECTABLE ANTICOAGULANTS MARKET SEGMENT BY TYPE

8.1 EMEA Injectable Anticoagulants Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
8.2 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
  10.2.1 EMEA Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017)
  10.2.2 EMEA Low-molecular-weight Heparin (LMWH) Price (2012-2017)
8.3 Direct Thrombin Inhibitor (DTI) Sales Growth and Price
  10.3.1 EMEA Direct Thrombin Inhibitor (DTI) Sales Growth (2012-2017)
  10.3.2 EMEA Direct Thrombin Inhibitor (DTI) Price (2012-2017)
8.4 Other Sales Growth and Price
  10.4.1 EMEA Other Sales Growth (2012-2017)
  10.4.2 EMEA Other Price (2012-2017)

9 EMEA INJECTABLE ANTICOAGULANTS MARKET SEGMENT BY APPLICATION

9.1 EMEA Injectable Anticoagulants Sales Market Share by Application (2012-2017)
9.2 VTE Sales Growth (2012-2017)
9.3 ACS/MI Sales Growth (2012-2017)
9.4 AF Sales Growth (2012-2017)
9.5 Other Sales Growth (2012-2017)

10 EMEA INJECTABLE ANTICOAGULANTS MARKET FORECAST (2017-2022)

10.1 EMEA Injectable Anticoagulants Sales, Revenue and Growth Rate (2017-2022)
10.2 Injectable Anticoagulants Market Forecast by Regions (2017-2022)
  10.2.1 Europe Injectable Anticoagulants Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.1.2 France Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.1.3 UK Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.1.4 Russia Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.1.5 Italy Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.1.6 Turkey Injectable Anticoagulants Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.2.2 Israel Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.2.3 UAE Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.2.4 Iran Injectable Anticoagulants Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.3.2 Nigeria Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.3.3 Egypt Injectable Anticoagulants Sales Forecast 2017-2022
    10.2.3.4 Algeria Injectable Anticoagulants Sales Forecast 2017-2022
10.3 Injectable Anticoagulants Market Forecast by Type (2017-2022)
10.4 Injectable Anticoagulants Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Injectable Anticoagulants Picture
Table Product Specifications of Injectable Anticoagulants
Figure EMEA Sales Market Share of Injectable Anticoagulants by Types in 2016
Table Injectable Anticoagulants Types for Major Manufacturers
Figure Low-molecular-weight Heparin (LMWH) Picture
Figure Direct Thrombin Inhibitor (DTI) Picture
Figure Other Picture
Table Injectable Anticoagulants Sales Market Share by Applications in 2016
Figure VTE Picture
Figure ACS/MI Picture
Figure AF Picture
Figure Other Picture
Figure Germany Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure France Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure UK Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Injectable Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Injectable Anticoagulants Type and Applications
Table Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) Injectable Anticoagulants Type and Applications
Table Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Injectable Anticoagulants Type and Applications
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Injectable Anticoagulants Type and Applications
Table Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table The Medicines Company Basic Information, Manufacturing Base and Competitors
Table The Medicines Company Injectable Anticoagulants Type and Applications
Table The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Injectable Anticoagulants Type and Applications
Table Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Injectable Anticoagulants Type and Applications
Table Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure EMEA Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure EMEA Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table EMEA Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure EMEA Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure EMEA Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table EMEA Injectable Anticoagulants Price by Manufacturer (2016-2017)
Figure EMEA Injectable Anticoagulants Sales and Growth (2012-2017)
Figure EMEA Injectable Anticoagulants Revenue and Growth (2012-2017)
Table EMEA Injectable Anticoagulants Sales by Regions (2012-2017)
Table EMEA Injectable Anticoagulants Sales Market Share by Regions (2012-2017)
Figure EMEA Injectable Anticoagulants Sales Market Share by Regions in 2012
Figure EMEA Injectable Anticoagulants Sales Market Share by Regions in 2016
Table EMEA Injectable Anticoagulants Revenue by Regions (2012-2017)
Table EMEA Injectable Anticoagulants Revenue Market Share by Regions (2012-2017)
Figure EMEA Injectable Anticoagulants Revenue Market Share by Regions in 2012
Figure EMEA Injectable Anticoagulants Revenue Market Share by Regions in 2016
Figure Europe Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Middle East Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Africa Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Europe Injectable Anticoagulants Revenue and Growth (2012-2017)
Table Europe Injectable Anticoagulants Sales by Countries (2012-2017)
Table Europe Injectable Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Europe Injectable Anticoagulants Sales Market Share by Countries in 2012
Figure Europe Injectable Anticoagulants Sales Market Share by Countries in 2016
Table Europe Injectable Anticoagulants Revenue by Countries (2012-2017)
Table Europe Injectable Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Europe Injectable Anticoagulants Revenue Market Share by Countries in 2012
Figure Europe Injectable Anticoagulants Revenue Market Share by Countries in 2016
Figure Germany Injectable Anticoagulants Sales and Growth (2012-2017)
Figure France Injectable Anticoagulants Sales and Growth (2012-2017)
Figure UK Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Russia Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Italy Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Turkey Injectable Anticoagulants Sales and Growth (2012-2017)
Table Europe Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure Europe Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Europe Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table Europe Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Europe Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Europe Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Europe Injectable Anticoagulants Sales by Type (2012-2017)
Table Europe Injectable Anticoagulants Sales Share by Type (2012-2017)
Table Europe Injectable Anticoagulants Sales by Application (2012-2017)
Table Europe Injectable Anticoagulants Sales Share by Application (2012-2017)
Figure Middle East Injectable Anticoagulants Revenue and Growth (2012-2017)
Table Middle East Injectable Anticoagulants Sales by Countries (2012-2017)
Table Middle East Injectable Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Middle East Injectable Anticoagulants Sales Market Share by Countries in 2012
Figure Middle East Injectable Anticoagulants Sales Market Share by Countries in 2016
Table Middle East Injectable Anticoagulants Revenue by Countries (2012-2017)
Table Middle East Injectable Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Middle East Injectable Anticoagulants Revenue Market Share by Countries in 2012
Figure Middle East Injectable Anticoagulants Revenue Market Share by Countries in 2016
Figure Saudi Arabia Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Israel Injectable Anticoagulants Sales and Growth (2012-2017)
Figure UAE Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Iran Injectable Anticoagulants Sales and Growth (2012-2017)
Table Middle East Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure Middle East Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Middle East Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table Middle East Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Middle East Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Middle East Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Middle East Injectable Anticoagulants Sales by Type (2012-2017)
Table Middle East Injectable Anticoagulants Sales Share by Type (2012-2017)
Table Middle East Injectable Anticoagulants Sales by Application (2012-2017)
Table Middle East Injectable Anticoagulants Sales Share by Application (2012-2017)
Figure Africa Injectable Anticoagulants Revenue and Growth (2012-2017)
Table Africa Injectable Anticoagulants Sales by Countries (2012-2017)
Table Africa Injectable Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Africa Injectable Anticoagulants Sales Market Share by Countries in 2012
Figure Africa Injectable Anticoagulants Sales Market Share by Countries in 2016
Table Africa Injectable Anticoagulants Revenue by Countries (2012-2017)
Table Africa Injectable Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Africa Injectable Anticoagulants Revenue Market Share by Countries in 2012
Figure Africa Injectable Anticoagulants Revenue Market Share by Countries in 2016
Figure South Africa Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Nigeria Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Egypt Injectable Anticoagulants Sales and Growth (2012-2017)
Figure Algeria Injectable Anticoagulants Sales and Growth (2012-2017)
Table Middle East Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure Middle East Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Middle East Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table Middle East Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Middle East Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Middle East Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Middle East Injectable Anticoagulants Sales by Type (2012-2017)
Table Middle East Injectable Anticoagulants Sales Share by Type (2012-2017)
Table Middle East Injectable Anticoagulants Sales by Application (2012-2017)
Table Middle East Injectable Anticoagulants Sales Share by Application (2012-2017)
Table EMEA Injectable Anticoagulants Sales by Type (2012-2017)
Table EMEA Injectable Anticoagulants Sales Share by Type (2012-2017)
Table EMEA Injectable Anticoagulants Revenue by Type (2012-2017)
Table EMEA Injectable Anticoagulants Revenue Share by Type (2012-2017)
Figure EMEA Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017)
Figure EMEA Low-molecular-weight Heparin (LMWH) Price (2012-2017)
Figure EMEA Direct Thrombin Inhibitor (DTI) Sales Growth (2012-2017)
Figure EMEA Direct Thrombin Inhibitor (DTI) Price (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Other Price (2012-2017)
Table EMEA Injectable Anticoagulants Sales by Application (2012-2017)
Table EMEA Injectable Anticoagulants Sales Share by Application (2012-2017)
Figure EMEA VTE Sales Growth (2012-2017)
Figure EMEA ACS/MI Sales Growth (2012-2017)
Figure EMEA AF Sales Growth (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Injectable Anticoagulants Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Injectable Anticoagulants Sales Forecast by Regions (2017-2022)
Table EMEA Injectable Anticoagulants Market Share Forecast by Regions (2017-2022)
Table Europe Injectable Anticoagulants Sales Forecast by Regions (2017-2022)
Figure Germany Injectable Anticoagulants Sales Forecast 2017-2022
Figure France Injectable Anticoagulants Sales Forecast 2017-2022
Figure UK Injectable Anticoagulants Sales Forecast 2017-2022
Figure Russia Injectable Anticoagulants Sales Forecast 2017-2022
Figure Italy Injectable Anticoagulants Sales Forecast 2017-2022
Figure Turkey Injectable Anticoagulants Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Injectable Anticoagulants Sales Forecast 2017-2022
Figure Israel Injectable Anticoagulants Sales Forecast 2017-2022
Figure UAE Injectable Anticoagulants Sales Forecast 2017-2022
Figure Iran Injectable Anticoagulants Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Injectable Anticoagulants Sales Forecast 2017-2022
Figure Nigeria Injectable Anticoagulants Sales Forecast 2017-2022
Figure Egypt Injectable Anticoagulants Sales Forecast 2017-2022
Figure Algeria Injectable Anticoagulants Sales Forecast 2017-2022
Table EMEA Injectable Anticoagulants Sales Forecast by Type (2017-2022)
Table EMEA Injectable Anticoagulants Market Share Forecast by Type (2017-2022)
Table EMEA Injectable Anticoagulants Sales Forecast by Application (2017-2022)
Table EMEA Injectable Anticoagulants Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List